XENE XENON PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Public Offering Xenon Pharmaceuticals Inc. entered into an underwriting agreement for a public offering of common shares and pre-funded warrants, expected to raise approximately $281.6 million.Get access to all SEC 8-K filings of the XENON PHARMACEUTICALS INC